您的位置:首页>>生化试剂>>小分子化合物>>10-2118 阿西替尼 Axitinib 319460-85-0
Cat. Number
10-2118
Chemical Name
10-2118 阿西替尼 Axitinib 319460-85-0
CAS Number
319460-85-0
Mol. Formula
C22H18N4OS
Mol. Weight
386.47
Qty 1
10mg
Qty 2
50mg
Appearance
White solid
Application Notes
99% by HPLC NMR (Conforms)
Synonym
N-Methyl-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
Solubility
Soluble in DMSO (up to 30 mg/ml)
Storage condition
-20°C (des.)
Stability
Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
References

Axitinib (319460-85-0) is a potent inhibitor of VEGFR-2, -3, and -1, IC50 = 0.2, 0.1-0.3, and 1.2 nM respectively1 displaying minimal activity against a panel of ~100 protein kinases. Inhibits angiogenesis and vascular permeability.2 Also inhibits BCR-ABL1 (T315I) with high potency, Ki = 149 pM for autophosphorylated ABL1 (T315I).3Inhibits proliferation of Ba/F3 cells expressing BCR-ABL1 (T315I). Axitinib is a clinically useful anticancer agent.4

References/Citations

1) Hu-Lowe et al. (2008), Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1,2,3; Cancer Res., 14 7272
2) Ma and Waxman (2008), Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib; Mol. Cancer Ther., 7 79
3) Pemovska et al. (2015), Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation; Nature, 519 102
4) Rixe et al. (2007), Axitinib treatment in patients with cytokine-refactory metastatic renal-cell cancer; a phase II study; Lancet Oncol., 8 975

Image 1

阿西替尼  英文名称Axitinib ,货号10-2118上海惠诚提供10mg 50mg 阿西替尼 Axitinib,美国focus原装进口,咨询电话021-60498804

阿西替尼  英文名称Axitinib ,货号10-2118上海惠诚提供10mg 50mg 阿西替尼 Axitinib,美国focus原装进口,咨询电话021-60498804

 

在线咨询 联系方式 二维码

服务热线

021-60498804

扫一扫,关注我们